X-group (possible homology)

2496 SpoIIaa-like

Ligands and drugs

1,509
Member domains
146
with ligand contacts (≤ 4 Å)
9.7% of members
136
with DrugDomain annotations
9.0% of members
86
with a DrugBank compound
5.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

23
Proteins with classified ligands
10
Superclasses bound (of 23)
9.6
Superclasses per 20 proteins
broader than 89% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds611.10.54×q = 0.06
Nucleosides, nucleotides, and analogues26.30.32×q = 0.09
Hydrocarbons10.26.31×not tested
Organosulfur compounds20.54.29×not tested
Lipids and lipid-like molecules102.53.96×not tested
Homogeneous non-metal compounds114.92.25×not tested
Benzenoids21.71.21×not tested
Organic oxygen compounds24.50.44×not tested
Organoheterocyclic compounds13.50.29×not tested
Organic acids and derivatives13.50.28×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00163VIVVitamin E16
DB00171ATPATP5
DB16833ADPAdenosine disphosphate5
DB03796PLMPalmitic Acid3
DB14094VTQTocopherylquinone3
DB18267HEMFerroheme3
DB02080TRT1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene2
DB04327PEEPhosphatidylethanolamine2
DB09459TLAL-tartaric acid2
DB11460SQLSqualene2
DB14001——2
DB14002——2
DB1685711AUndecanoic acid2

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION18
VIV(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL13
B7N(1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate7
NAmetalSODIUM ION7
IODIODIDE ION6
LBN1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine6
ATPADENOSINE-5'-TRIPHOSPHATE5
PEV(1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE5
3PT(2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dibutanoate4
C14TETRADECANE4
D10DECANE4
NImetalNICKEL (II) ION4
OCTN-OCTANE4
POPPYROPHOSPHATE 2-4
PTYPHOSPHATIDYLETHANOLAMINE4
RETRETINAL4
6PL(4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE3
HEMPROTOPORPHYRIN IX CONTAINING FE3
MGmetalMAGNESIUM ION3
PBU(2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL DIBUTANOATE3